Sorry, the video which you have requested is not yet processed.

Filter By:
03:23
With many therapy options to consider, how can patients best discuss their CLL treatment options with their doctor? A CLL expert from Seattle Cancer Care Alliance, Dr. David Maloney, discusses his approach to determining when to treat and what factors—includi​ng age and pre-existing conditions—he con...
by:patientpower | 24 views
04:15
MPN symptoms can be ver frustrating for MPN patients. At our recent MPN Forum in Chicago, Dr. Brady Stein from Northwestern Medicine and Dr. Alison Moliterno from Johns Hopkins Medicine discuss one of the most common MPN symptoms, itching. The experts share what they know about why itching occurs and some possible remedies. Get email alerts ...
by:patientpower | 28 views
02:16
Doctors and patients alike have shown excitement over a new generation of novel agents for the treatment of non-Hodgkin lymphoma that allows some patients to take continuous, oral medications with less toxicity than traditional chemotherapy. While these drugs may offer kinder, gentler treatment path...
by:patientpower | 36 views
09:18
What are granulocytes, and how do they impact your lab results? Laboratory scientist Dr. Susan Leclair helps us understand the function of some white blood cells (WBC), how they are counted, and how certain strenuous activities may impact your lab test results. Get email alerts | http://www.......
by:patientpower | 35 views
05:49
When is it time to consider treatment? How and what symptoms do you communicate to your healthcare team? At our recent MPN Forum in Chicago, Dr. Alison Moliterno, Dr. Brady Stein and Nurse Clinician, Amy Brich, address the questions surrounding treatment considerations. The experts explore the sympt...
by:patientpower | 43 views
02:28
http://cance... Will the success seen for stage IV patients receiving targeted therapies translate into cure for stage III patients? Dr. Daniel Morgensztern of the Washington University School of Medicine talks about what research is ongoing to answer that question. GRACEcast 266 Lung
by:cancergrace | 134 views
04:33
In this video Professor Chris Pepper of The Cardiff CLL Research Group, Institute of Cancer & Genetics at Cardiff University tells us a little about himself and how he became involved in CLL research, the work of the CLL research team and the Cancer Research Genetics Building and provides us wit...
by:PatientPowerEU | 210 views
02:08
Different drug combinations have different toxicity profiles, associated complications and efficacy. Requiring lengthy discussion between patients and their doctor and treatment at a centre experienced in their delivery and care of patients being treated with them. Q1) Many patient’s have hea...
by:PatientPowerEU | 422 views
02:36
The new targeted therapies will require discipline and engagement by patients to ensure they take their medications to stay in remission. Longer term the research community is working towards novel none chemo combinations that may produce a durable MRD status, removing the need then for continued m...
by:PatientPowerEU | 327 views
03:05
Much discussion is required between the patient and doctor when understanding where you are, as tests may be better at predicting for populations and there is much individual variation to consider. Q1) What are the most important clinical tests for CLL patients to take? Q2) What genetic techniqu...
by:PatientPowerEU | 283 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)